FORNARO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 956
EU - Europa 315
AS - Asia 130
OC - Oceania 2
SA - Sud America 2
Totale 1.405
Nazione #
US - Stati Uniti d'America 953
SE - Svezia 127
IT - Italia 84
SG - Singapore 69
CN - Cina 40
DE - Germania 32
FR - Francia 25
GB - Regno Unito 19
BE - Belgio 12
FI - Finlandia 8
IN - India 8
CZ - Repubblica Ceca 5
JP - Giappone 4
VN - Vietnam 4
CA - Canada 3
IR - Iran 3
AU - Australia 2
AR - Argentina 1
EE - Estonia 1
ES - Italia 1
GF - Guiana Francese 1
KR - Corea 1
RO - Romania 1
TH - Thailandia 1
Totale 1.405
Città #
Chandler 170
Fairfield 114
Nyköping 114
Ashburn 65
Cambridge 49
Houston 49
Singapore 47
Woodbridge 43
Seattle 40
Wilmington 36
Ann Arbor 27
Lawrence 26
New York 22
Roxbury 18
Inglewood 17
Bari 16
Munich 16
Beijing 14
Des Moines 13
Brussels 12
Princeton 9
Helsinki 7
Los Angeles 7
London 6
Paris 6
Redwood City 6
Santa Clara 6
Modugno 5
Naples 5
Pune 5
Brno 4
Dong Ket 4
Nanjing 4
San Diego 4
San Francisco 4
Shanghai 4
Trani 4
Brooklyn 3
Florence 3
Hebei 3
Leawood 3
San Mateo 3
Toronto 3
Ardabil 2
Brindisi 2
Cerveteri 2
Dearborn 2
Frankfurt am Main 2
Massa 2
Monmouth Junction 2
Mumbai 2
Prescot 2
Saint-Fons 2
Verdellino 2
Wuhan 2
Augusta 1
Berlin 1
Bitonto 1
Brugherio 1
Campo San Martino 1
Canberra 1
Clifton 1
Esslingen am Neckar 1
Greenwich 1
Grottaglie 1
Haikou 1
Hat Yai 1
Hounslow 1
Jacksonville 1
Kilburn 1
Madrid 1
Melbourne 1
Milan 1
Mola Di Bari 1
Mountain View 1
Nagold 1
Nanchang 1
Norwalk 1
Olomouc 1
Remire-Montjoly 1
Shenyang 1
Tallinn 1
Tianjin 1
Tokyo 1
Washington 1
Totale 1.070
Nome #
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 107
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 106
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 91
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 85
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 84
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 74
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 68
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 58
Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis 56
Sindrome anti-sintetasi: due casi di anti-EJ (anti-glycyl-tRNAsintetasi) 47
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 46
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 46
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 44
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 42
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 36
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 35
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study 30
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 30
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 30
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 30
Cartilage damage: clinical approach 30
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 28
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 28
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 27
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 24
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 20
Complete Hydatidiform Mole Mimicking Sacroiliitis 17
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 16
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 16
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 14
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 11
Predictors of long-term clinical remission in rheumatoid arthritis 10
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 9
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 9
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 8
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 8
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 8
Letters to the editors 8
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 8
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 7
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 7
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 5
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 5
Body mass index and adipokines/cytokines dysregulation in Systemic Sclerosis 4
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 3
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 3
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry 3
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry 3
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 3
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 2
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 2
Integrating large language models in medicine: a study of Claude 2’s performance in MDAAT scoring for idiopathic inflammatory myopathies 2
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study 1
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the biologic apulian registry (BIOPURE) 1
Mobile session fixation attack in micropayment systems 1
Totale 1.496
Categoria #
all - tutte 10.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020208 0 0 2 15 14 29 26 32 35 23 20 12
2020/2021194 5 14 9 6 18 15 22 23 22 19 31 10
2021/2022226 9 2 5 10 9 11 25 14 17 30 32 62
2022/2023455 46 76 30 31 30 69 9 66 61 6 19 12
2023/2024222 17 45 13 19 13 41 9 6 3 7 4 45
2024/2025119 43 14 62 0 0 0 0 0 0 0 0 0
Totale 1.496